Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation

被引:46
|
作者
Bruchfeld, Annette [1 ]
Carrero, Juan J. [2 ]
Qureshi, Abdul R. [2 ]
Lindholm, Bengt [2 ]
Barany, Peter
Heimburger, Olof
Hu, Maowen [3 ]
Lin, Xinchun [3 ]
Stenvinkel, Peter
Miller, Edmund J. [3 ,4 ]
机构
[1] Karolinska Univ Hosp Huddinge, Div Renal Med, Dept Clin Sci Intervent & Technol, Karolinska Inst,CLINTEC, S-14186 Huddinge, Sweden
[2] Karolinska Inst, CLINTEC, Baxter Novum, Stockholm, Sweden
[3] Feinstein Inst Med Res, Manhasset, NY USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
基金
英国医学研究理事会;
关键词
HUMAN ATHEROSCLEROTIC PLAQUES; CHRONIC-RENAL-FAILURE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; TNF-ALPHA; INTERLEUKIN-6; MALNUTRITION; INFLAMMATION; EXPRESSION; MORTALITY;
D O I
10.2119/molmed.2008.00109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic kidney disease (CKD) carries an increased risk of cardiovascular disease (CVD). Macrophage migration inhibiting factor (MIF) is a proinflammatory cytokine implicated in the pathogenesis of sepsis, autoimmune disease, atherogenesis, and plaque instability, and is a known cardiac depressant. This post-hoc, cross-sectional study examined whether MIF serum concentrations are elevated in CKD patients. Our study included CKD 3-5 patients with moderate to severe renal dysfunction (n = 257) (mean age SD; 55 +/- 12 years) and 53 controls (60 +/- 12 years). Serum MIF concentrations, measured by enzyme-linked immunosorbent assay (ELISA), were studied in relation to glomerular filtration rate (GFR), presence of CVD, outcome and inflammatory and oxidative stress markers. MIF was significantly elevated in CKD patients compared with controls (CKD: median 676 (range 118-8275 pg/mL) controls: 433 (142-4707) pg/mL: P = 0.008). MIF was also associated with 8-hydroxy-2-deoxyguanosine (8-OH-dG) levels (rho = 0.26: P = 0.001), a marker of oxidative stress, and ICAM-1 levels (rho = 0.14, P = 0.02), a marker of endothelial activation. However, the elevated MIF concentrations were neither correlated with glomerular filtration rate (GFR) nor inflammatory markers such as CRP. IL-6, and TNF. When combining MIF and IL-6 as a marker of inflammation, a significant increase in risk for CVD was found, but when analyzing all-cause mortality, this did not differ significantly with regard to mortality from inflamed patients with low MIF levels. The data suggest that increased serum MIF levels found in CKD is not caused primarily by poor renal function, but is associated with markers of oxidative stress and endothelial activation and may play a role in vascular disease associated with CKD. (C) 2009 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: http://www.molmed.org doi: 10.2119/molmed.2008.00109
引用
收藏
页码:70 / 75
页数:6
相关论文
共 50 条
  • [21] Elevated concentrations of macrophage migration inhibitory factor in serum and cerebral microdialysate are associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
    Neumaier, Felix
    Stoppe, Christian
    Stoykova, Anzhela
    Weiss, Miriam
    Veldeman, Michael
    Hoellig, Anke
    Hamou, Hussam Aldin
    Temel, Yasin
    Conzen, Catharina
    Schmidt, Tobias Philip
    Dogan, Rabia
    Wiesmann, Martin
    Clusmann, Hans
    Schubert, Gerrit Alexander
    Haeren, Roel Hubert Louis
    Albanna, Walid
    FRONTIERS IN NEUROLOGY, 2023, 13
  • [22] Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor
    Nicoletti, Alessandra
    Fagone, Paolo
    Donzuso, Giulia
    Mangano, Katia
    Dibilio, Valeria
    Caponnetto, Salvatore
    Bendtzen, Klaus
    Zappia, Mario
    Nicoletti, Ferdinando
    CYTOKINE, 2011, 55 (02) : 165 - 167
  • [23] A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis
    J A Baugh
    S Chitnis
    S C Donnelly
    J Monteiro
    X Lin
    B J Plant
    F Wolfe
    P K Gregersen
    R Bucala
    Genes & Immunity, 2002, 3 : 170 - 176
  • [24] A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis
    Baugh, JA
    Chitnis, S
    Donnelly, SC
    Monteiro, J
    Lin, X
    Plant, BJ
    Wolfe, F
    Gregersen, PK
    Bucala, R
    GENES AND IMMUNITY, 2002, 3 (03) : 170 - 176
  • [25] SERUM MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) LEVEL PREDICTS ACUTE CHEST SYNDROME IN PATIENTS WITH SICKLE CELL DISEASE
    Ahmed, Rafat
    Linge, Helena
    Vanan, Issai
    Apollonsky, Nataly
    Miller, Edmund
    Vlachos, Adrianna
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 832 - 833
  • [26] Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
    Younan, Doreen Nazeih Assaad
    Agamia, Naglaa
    Elshafei, Adel
    Ebeid, Nancy
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2015, 29 (01) : 74 - 79
  • [27] Iguratimod, an allosteric inhibitor of macrophage migration inhibitory factor (MIF), prevents mortality and oxidative stress in a murine model of acetaminophen overdose
    Bloom, Joshua
    Pantouris, Georgios
    He, Mingzhu
    Aljabari, Bayan
    Mishra, Lopa
    Manjula, Ramu
    Parkins, Andrew
    Lolis, Elias J.
    Al-Abed, Yousef
    MOLECULAR MEDICINE, 2024, 30 (01)
  • [28] Iguratimod, an allosteric inhibitor of macrophage migration inhibitory factor (MIF), prevents mortality and oxidative stress in a murine model of acetaminophen overdose
    Joshua Bloom
    Georgios Pantouris
    Mingzhu He
    Bayan Aljabari
    Lopa Mishra
    Ramu Manjula
    Andrew Parkins
    Elias J. Lolis
    Yousef Al-Abed
    Molecular Medicine, 30
  • [29] Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity
    Wakabayashi, Kuninobu
    Otsuka, Kumiko
    Sato, Michihito
    Takahashi, Ryo
    Odai, Tsuyoshi
    Isozaki, Takeo
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 59 - 65
  • [30] Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance
    Vozarova, B
    Stefan, N
    Hanson, R
    Lindsay, RS
    Bogardus, C
    Tataranni, PA
    Metz, C
    Bucala, R
    DIABETOLOGIA, 2002, 45 (12) : 1739 - 1741